Type 2 Diabetes Resources Chosen by Advanced Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), like semaglutide, are widely used for managing diabetes and weight loss. However, their extended use raises concerns about their impact on immune responses,...

Age Influences Efficacy of Diabetes Medications in Reducing Cardiovascular Risk and HbA1c

In a study, researchers aimed to evaluate how age and sex influence the efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors,...
Tina Copple,
CURATED BY:
Tina Copple,
DNP, APRN, FNP-BC, ADM-BC, CDCES

Study Finds No Increased Thyroid Cancer Risk With GLP-1 Receptor Agonists in Type 2 Diabetes

A recent study found no significant difference in the risk of thyroid cancer between adults with type 2 diabetes using...
Tina Copple,
CURATED BY:
Tina Copple,
DNP, APRN, FNP-BC, ADM-BC, CDCES

Empagliflozin Reduces Risk of Cardiovascular Events in Heart Failure With Preserved Ejection Fraction

A double-blind trial was conducted to assess the effects of empagliflozin in patients with heart failure and preserved ejection fraction....
Ashlyn Smith,
CURATED BY:
Ashlyn Smith,
MMS, PA-C

Physician Associate and Nurse Practitioner Contributors to the Type 2 Diabetes Center of Excellence

POCN’s Type 2 Diabetes Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Share